ClearBridge Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

ClearBridge Investments’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,572,404	Closed	-$66.3M	–	719
2023 Q2	$66.3M	Sell	1,572,404 -2,576,524	-62%	-$104M	0.06%	282
2023 Q1	$148M	Buy	4,148,928 +2,814	+0.1%	+$102K	0.14%	159
2022 Q4	$152M	Sell	4,146,114 -61,510	-1%	-$2.43M	0.15%	148
2022 Q3	$198M	Buy	4,207,624 +85,886	+2%	+$5.55M	0.2%	124
2022 Q2	$295M	Buy	4,121,738 +219,576	+6%	+$16.1M	0.28%	94
2022 Q1	$316M	Buy	3,902,162 +125,011	+3%	+$10.6M	0.24%	102
2021 Q4	$388M	Buy	3,777,151 +101,104	+3%	+$9.71M	0.26%	95
2021 Q3	$322M	Buy	3,676,047 +30,311	+0.8%	+$2.74M	0.23%	102
2021 Q2	$326M	Buy	3,645,736 +117,923	+3%	+$9.96M	0.23%	106
2021 Q1	$268M	Sell	3,527,813 -37,896	-1%	-$2.86M	0.2%	115
2020 Q4	$243M	Buy	3,565,709 +132,484	+4%	+$8.26M	0.19%	119
2020 Q3	$183M	Buy	3,433,225 +193,144	+6%	+$11.5M	0.16%	132
2020 Q2	$189M	Sell	3,240,081 -268,379	-8%	-$14.4M	0.17%	121
2020 Q1	$138M	Sell	3,508,460 -216,537	-6%	-$12.7M	0.15%	137
2019 Q4	$222M	Buy	3,724,997 +137,037	+4%	+$7.37M	0.18%	123
2019 Q3	$191M	Buy	3,587,960 +61,805	+2%	+$3.17M	0.17%	135
2019 Q2	$180M	Buy	3,526,155 +245,467	+7%	+$11.4M	0.16%	145
2019 Q1	$170M	Buy	3,280,688 +110,268	+3%	+$5.35M	0.15%	152
2018 Q4	$125M	Sell	3,170,420 -59,878	-2%	-$2.78M	0.13%	166
2018 Q3	$167M	Buy	3,230,298 +379,235	+13%	+$18.6M	0.14%	154
2018 Q2	$134M	Buy	2,851,063 +531,588	+23%	+$22M	0.11%	175
2018 Q1	$82.3M	Buy	2,319,475 +248,889	+12%	+$9.75M	0.08%	227
2017 Q4	$90.3M	Buy	2,070,586 +931,251	+82%	+$43.5M	0.08%	222
2017 Q3	$59.6M	Buy	1,139,335 +115,881	+11%	+$6.46M	0.06%	285
2017 Q2	$59.9M	Buy	1,023,454 +2,201	+0.2%	+$114K	0.06%	285
2017 Q1	$46.8M	Buy	1,021,253 +10,427	+1%	+$519K	0.05%	325
2016 Q4	$53.2M	Sell	1,010,826 -35	-0%	-$1.69K	0.06%	278
2016 Q3	$45.1M	Sell	1,010,861 -2,045	-0.2%	-$88.7K	0.05%	297
2016 Q2	$38.6M	Sell	1,012,906 -55,952	-5%	-$2.46M	0.05%	308
2016 Q1	$44M	Sell	1,068,858 -15,044	-1%	-$620K	0.05%	290
2015 Q4	$52.6M	Sell	1,083,902 -9,808	-0.9%	-$436K	0.06%	264
2015 Q3	$43.7M	Sell	1,093,710 -40,269	-4%	-$1.76M	0.05%	285
2015 Q2	$45.5M	Buy	1,133,979 +212,740	+23%	+$7.34M	0.05%	314
2015 Q1	$30.2M	Buy	921,239 +20,470	+2%	+$565K	0.03%	379
2014 Q4	$23.1M	Buy	+900,769	New	+$21.4M	0.02%	421

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ClearBridge Investments's SYNH Position: Q3 2023 in Review

ClearBridge Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,572,404 shares — an estimated $66.3M sold.

ClearBridge Investments first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $388M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

ClearBridge Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
ClearBridge Investments sold 1,572,404 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $66.3M.
ClearBridge Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
ClearBridge Investments's Syneos Health, Inc. Class A Common Stock position peaked at $388M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on ClearBridge Investments's 13F filing for Q3 2023, filed 13 Nov 2023.